Satellos Bioscience Inc. Market Cap ($138.13 Million)
Market Cap & Net Worth: Satellos Bioscience Inc. (MSCL)
Satellos Bioscience Inc. market cap. Satellos Bioscience Inc. (TO:MSCL) has a market capitalization of $138.13 Million (CA$190.95 Million) as of November 5, 2026. Listed on the TO stock exchange, this Canada-based company holds position #17768 globally and #565 in its home market, demonstrating a -3.54% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Satellos Bioscience Inc.'s stock price CA$9.00 by its total outstanding shares 21216439 (21.22 Million). Also see MSCL operating cash flow for how efficiently the company converts equity into cash flow.
Satellos Bioscience Inc. Market Cap History (2015–2026)
Satellos Bioscience Inc. market cap history from 2015 to 2026. Data shows growth from $12.28 Million to $138.13 Million (18.34% CAGR). Check Satellos Bioscience Inc. stock quote for real-time trading data and today's change.
Satellos Bioscience Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Satellos Bioscience Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of Satellos Bioscience Inc. to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
982.25x
Satellos Bioscience Inc.'s market cap is 982.25 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $24.56 Million | $25.00K | -$1.94 Million | 982.25x | N/A |
Competitor Companies of MSCL by Market Capitalization
Companies near Satellos Bioscience Inc. in the global market cap rankings as of November 5, 2026. Also see Satellos Bioscience Inc. assets under control for a full breakdown of the balance sheet.
Key companies related to Satellos Bioscience Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #368 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #414 globally with a market cap of $68.22 Billion USD ( AU$96.41 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $530.76 |
| #368 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $973.36 |
| #414 | CSL Ltd | AU:CSL | $68.22 Billion | AU$198.72 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $228.44 |
Market Capitalization of Satellos Bioscience Inc. (2015–2026)
Market capitalization of Satellos Bioscience Inc. from 2015 to today. Between 2015 and today, Satellos Bioscience Inc.'s market cap moved from $12.28 Million to $ 138.13 Million, with a yearly change of 18.34%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$138.13 Million | +1263.64% |
| 2025 | CA$10.13 Million | -20.48% |
| 2024 | CA$12.74 Million | +93.02% |
| 2023 | CA$6.60 Million | +95.45% |
| 2022 | CA$3.38 Million | -78.00% |
| 2021 | CA$15.35 Million | -16.67% |
| 2020 | CA$18.42 Million | -25.00% |
| 2019 | CA$24.56 Million | +60.00% |
| 2018 | CA$15.35 Million | +25.00% |
| 2017 | CA$12.28 Million | -20.00% |
| 2016 | CA$15.35 Million | +25.00% |
| 2015 | CA$12.28 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Satellos Bioscience Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $138.13 Million USD |
| MoneyControl | $138.13 Million USD |
| MarketWatch | $138.13 Million USD |
| marketcap.company | $138.13 Million USD |
| Reuters | $138.13 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Satellos Bioscience Inc.
Satellos Bioscience Inc., a clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia. The company uses its proprietary discovery platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. It develops SAT-3247, an oral, small m… Read more